Functional echocardiography; from physiology to treatment

Early Human Development

Volumn 86, Issue 3, 2010, Pages 149-154

  de Waal, Koert ^a   Kluckow, Martin ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cardiac output; Echocardiography; Newborn

Indexed keywords

CARDIOVASCULAR AGENT; IBUPROFEN; INDOMETACIN; MILRINONE; NITRIC OXIDE; SILDENAFIL; VASODILATOR AGENT;

ADJUVANT THERAPY; AORTA FLOW; BLOOD PRESSURE MEASUREMENT; CAPILLARY FLOW; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DOPPLER ECHOGRAPHY; DUCTUS ARTERIOSUS; EARLY DIAGNOSIS; EARLY INTERVENTION; ECHOCARDIOGRAPHY; HEALTH PROGRAM; HEART CONTRACTION; HEART FUNCTION TEST; HEART HEMODYNAMICS; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; NEWBORN DISEASE; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; PULMONARY HYPERTENSION; RESUSCITATION; REVIEW; SEPSIS; VERY LOW BIRTH WEIGHT;

CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PRACTICE GUIDELINES AS TOPIC;

EID: 77950339132     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.01.030     Document Type: Review

References (72)

1. Kluckow M., Seri I., Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr 2007, 150:125-130.
2. Kluckow M., Seri I., Evans N. Echocardiography and the neonatologist. Pediatr Cardiol 2008, 29:1043-1047.
3. Mayo P.H., Beaulieu Y., Doelken P., Feller-Kopman D., Harrod C., Kaplan A., et al. American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest 2009, 135:1050-1060.
4. Wright J., Jarman R., Connolly J., Dissmann P. Echocardiography in the emergency department. Emerg Med J 2009, 26:82-86.
5. Australasian Society for Ultrasound in Medicine: Certificate in Clinician Performed Ultrasound. Retrieved December 2009 from http://www.asum.com.au/ccpu.
6. Dempsey E.M., Al Hazzani F., Barrington K.J. Permissive hypotension in the extremely low birthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed 2009, 94:F241-F244.
7. Fanaroff J.M., Wilson-Costello D.E., Newman N.S., Montpetite M.M., Fanaroff A.A. Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics 2006, 117:1131-1135.
8. Batton B., Zhu X., Fanaroff J., Kirchner H.L., Berlin S., Wilson-Costello D., et al. Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants. J Pediatr 2009, 154:351-357.
9. Osborn D.A. Diagnosis and treatment of preterm transitional circulatory compromise. Early Hum Dev May 2005, 81:413-422.
10. Evans N. Assessment and support of the preterm circulation. Early Hum Dev 2006, 82:803-810.
11. Evans N., Kluckow M. Early determinants of right and left ventricular output in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996, 74:F88-F94.
12. Kluckow M., Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000, 82:F188-F194.
13. Lundstrøm K., Pryds O., Greisen G. The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev 2000, 57:157-163.
14. Osborn D., Evans N., Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002, 140:183.
15. Paradisis M., Evans N., Kluckow M., Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009, 154:189-195.
16. Valverde E., Pellicer A., Madero R., Elorza D., Quero J., Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics 2006, 117:e1213-e1222.
17. Evans N., Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995, 72:F156-F161.
18. Groves A.M., Kuschel C.A., Knight D.B., Skinner J.R. Does retrograde diastolic flow in the descending aorta signify impaired systemic perfusion in preterm infants?. Pediatr Res 2008, 63:89-94.
19. Evans N. Support of the preterm circulation: keynote address to the Fifth Evidence vs Experience Conference, Chicago, June 2008. J Perinatol 2009, 29:S507.
20. Sarkar S., Dechert R., Schumacher R.E., Donn S.M. Is refractory hypotension in preterm infants a manifestation of early ductal shunting?. J Perinatol 2007, 27:353-358.
21. Amin S.B., Handley C., Carter-Pokras O. Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol 2007, 28:193-200.
22. Hoellering A.B., Cooke L. The management of patent ductus arteriosus in Australia and New Zealand. J Paediatr Child Health 2009, 45:204-209.
23. Fowlie P.W., Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002, CD000174.
24. Kluckow M., Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995, 127:774-779.
25. Cooke L., Steer P., Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003, CD003745.
26. Aranda J.V., Clyman R., Cox B., Van Overmeire B., Wozniak P., Sosenko I., et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen l-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009, 26:235-245.
27. Urquhart D.S., Nicholl R.M. How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate?. Arch Dis Child 2003, 88:85-86.
28. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., Fanaroff A. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007, 150:229-234. 234.e1.
29. Madan J.C., Kendrick D., Hagadorn J.I., Frantz I.D. National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009, 123:674-681.
30. Echocardiography for the neonatologist 2000, 1-243. Churchill Livingstone, London. J. Skinner, D. Dale Alverson, S. Hunter (Eds.).
31. Sehgal A., McNamara P.J. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?. Eur J Pediatr 2009, 168:907-914.
32. McNamara P.J., Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007, 92:F424-F427.
33. Abman S.H. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology 2007, 91:283-290.
34. Musewe N.N., Smallhorn J.F., Benson L.N., Burrows P.E., Freedom R.M. Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation 1987, 76:1081-1091.
35. Phillipos E.Z., Robertson M.A., Byrne P.J. Serial assessment of ductus arteriosus hemodynamics in hyaline membrane disease. Pediatrics 1996, 98:1149-1153.
36. Day R.W., Lynch J.M., White K.S., Ward R.M. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996, 98:698-705.
37. Skinner J.R., Boys R.J., Heads A., Hey E.N., Hunter S. Estimation of pulmonary arterial pressure in the newborn: study of the repeatability of four Doppler echocardiographic techniques. Pediatr Cardiol 1996, 17:360-369.
38. King M.E., Braun H., Goldblatt A., Liberthson R., Weyman A.E. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation 1983, 68:68-75.
39. Skinner J.R., Hunter S., Hey E.N. Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal Neonatal Ed 1996, 74:F26-F32.
40. Evans N., Kluckow M., Currie A. Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed 1998, 78:F105-F111.
41. Peterson A.L., Deatsman S., Frommelt M.A., Mussatto K., Frommelt P.C. Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. Pediatr Cardiol 2009 Feb, 30:160-165.
42. Konduri G.G., Kim U.O. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 2009, 56:579-600.
43. Thébaud B., Tibboel D. Pulmonary hypertension associated with congenital diaphragmatic hernia. Cardiol Young 2009, 19:49-53.
44. Cheung P.Y., Barrington K.J. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 2001, 5:158-166.
45. Tourneux P., Rakza T., Bouissou A., Krim G., Storme L. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension. J Pediatr 2008, 153:345-349.
46. McNamara P.J., Laique F., Muang-In S., Whyte H.E. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006, 21:217-222.
47. Shah P.S., Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev Jul 18 2007, CD005494.
48. Patel N., Mills J.F., Cheung M.M. Use of the myocardial performance index to assess right ventricular function in infants with pulmonary hypertension. Pediatr Cardiol 2009, 30:133-137.
49. Patel N., Mills J.F., Cheung M.M. Assessment of right ventricular function using tissue Doppler imaging in infants with pulmonary hypertension. Neonatology 2009, 96:193-199.
50. Nestaas E., Støylen A., Brunvand L., Fugelseth D. Tissue Doppler derived longitudinal strain and strain rate during the first 3days of life in healthy term neonates. Pediatr Res 2009, 65:357-362.
51. Wyckoff M.H., Perlman J.M., Laptook A.R. Use of volume expansion during delivery room resuscitation in near-term and term infants. Pediatrics 2005, 115:950-955.
52. Ranjit M.S. Cardiac abnormalities in birth asphyxia. Indian J Pediatr 2000, 67:52932.
53. Barberi I., Calabrò M.P., Cordaro S., Gitto E., Sottile A., Prudente D., et al. Myocardial ischaemia in neonates with perinatal asphyxia. Electrocardiographic, echocardiographic and enzymatic correlations. Eur J Pediatr 1999, 158:742-747.
54. Wei Y., Xu J., Xu T., Fan J., Tao S. Left ventricular systolic function of newborns with asphyxia evaluated by tissue Doppler imaging. Pediatr Cardiol 2009, 30(6):7416.
55. Robel-Tillig E., Knüpfer M., Pulzer F., Vogtmann C. Cardiovascular impact of dobutamine in neonates with myocardial dysfunction. Early Hum Dev 2007, 83:30712.
56. Russell J.A. Management of sepsis. N Engl J Med. 2006, 355:1699-1713.
57. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595.
58. Klijn E., Den Uil C.A., Bakker J., Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med 2008 Dec, 29:643-654.
59. Spronk P.E., Zandstra D.F., Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004, 8:462-468.
60. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
61. de Oliveira C.F., de Oliveira D.S., Gottschald A.F., Moura J.D., Costa G.A., Ventura A.C., et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 2008, 34:1065-1075.
62. Ceneviva G., Paschall J.A., Maffei F., Carcillo J.A. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998, 102:e19.
63. Brierley J., Peters M.J. Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care. Pediatrics 2008, 122:752-759.
64. Meadow W., Rudinsky B. Inflammatory mediators and neonatal sepsis. Rarely has so little been known by so many about so much. Clin Perinatol 1995, 22:519-536.
65. de Waal K.A., Evans N. Hemodynamic presentation of late onset sepsis in preterm infants. J Paediatr Child Health 2009, 45:A84.
66. Brierley J., Carcillo J.A., Choong K., Cornell T., Decaen A., Deymann A., et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009, 37:666-688.
67. Metrangolo L., Fiorillo M., Friedman G., Silance P.G., Kahn R.J., Novelli G.P., et al. Early hemodynamic course of septic shock. Crit Care Med 1995, 23:1971-1975.
68. Skinner J.R. Echocardiography on the neonatal unit: a job for the neonatologist or the cardiologist?. Arch Dis Child 1998, 78:401-402.
69. Whitehall J. Echocardiography by a neonatologist. Arch Dis Child 1999, 80:580-581.
70. Moss S., Kitchiner D.J., Yoxall C.W., Subhedar N.V. Evaluation of echocardiography on the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2003, 88:F287-F289.
71. CD-Rom, Evans N, Malcolm G (2006) Practical echocardiography for the neonatologist: Part 1. Normal 2D imaging and Doppler: an interactive multimedia CDROM. Royal Prince Alfred Hospital, Sydney, Australia.
72. Australian New Zealand Clinical Trials Registry. Targeting of treatment of the patent ductus arteriosus using early echocardiography (DETECT). ID# ACTRN 12608000295347. Retrieved December 2009 at http://www.anzctr.org.au.